automatyka-robotyka

Blood management in a patient

Blood administration in a affected person with anti-Okay a antibody who underwent cardiac surgical procedure utilizing cardiopulmonary bypass: a case report

Background: The Cardiac surgical procedure underneath cardiopulmonary bypass (CPB) is commonly related to huge bleeding and blood transfusion. For sufferers requiring particular blood merchandise, meticulous blood administration is vital to cut back blood loss, in addition to the necessity for transfusion. Right here, now we have described the intraoperative blood administration in a affected person with anti-Okaya antibody, who underwent cardiac surgical procedure with CPB.
Case presentation: A 79-year-old girl was scheduled for open aortic valve substitute and tricuspid valve annuloplasty underneath hypothermic CPB. Her blood kind was A RhD(+) Okay(a-), and anti-Okaya, an especially uncommon antibody towards erythrocyte antigen, was detected. Eight models of Okay(a-) frozen thawed pink cells (FTRCs), and 6 models of pink blood cells donated by three Okay(a-) people had been collected simply previous to surgical procedure.
Though she was anemic, acute normovolemic hemodilution was carried out after anesthesia induction to protect the autologous complete blood. 4 models of FTRCs had been loaded within the CPB priming answer, and modified ultrafiltration was adopted throughout CPB to stop additional hemodilution. After CPB termination, two models of FTRCs, 4 models of recent frozen plasma, and ten models of platelet focus had been intensively transfused, facilitating surgical hemostasis and secure hemodynamics
. The autologous complete blood was returned to the affected person within the intensive care unit. Because the hemoglobin and hematocrit ranges had been maintained postoperatively, no further transfusion was required all through her hospital keep.
Conclusions: Multidisciplinary intraoperative blood administration in a affected person with anti-Okaya antibody facilitated profitable cardiac surgical procedure utilizing CPB, together with efficient use of restricted blood merchandise.
automation-robotics

automation-robotics

Anti-Human LEC (CCL16)
MBS550695-01mg 0.1mg
EUR 260

Anti-Human LEC (CCL16)
MBS550695-02mg 0.2mg
EUR 335

Recombinant Human LEC
MBS7608806-005mg 0.05mg
EUR 345

Recombinant Human LEC
MBS7608806-02mg 0.2mg
EUR 635

Recombinant Human LEC
MBS7608806-1mg 1mg
EUR 1800

Recombinant Human LEC
MBS7608806-5x1mg 5x1mg
EUR 6955

Recombinant Human LEC (CCL16)
Z100325 25 µg
EUR 235
Description: CCL16 is a CC chemokine that specifically attracts lymphocytes, dendritic cells, and monocytes; increases their adhesive properties and has myelosuppressive activity. It is constitutively expressed in liver and is increased by interleukin 10 (IL-10) in activated monocytes. CCL16 is present in human plasma suggesting that it may be active outside hepatic tissue. CCR1, CCR2, CCR5, and CCR8 are the functional receptors of this chemokine.

Recombinant Human LEC (CCL16)
Z100329 1.0 mg
EUR 3900
Description: CCL16 is a CC chemokine that specifically attracts lymphocytes, dendritic cells, and monocytes; increases their adhesive properties and has myelosuppressive activity. It is constitutively expressed in liver and is increased by interleukin 10 (IL-10) in activated monocytes. CCL16 is present in human plasma suggesting that it may be active outside hepatic tissue. CCR1, CCR2, CCR5, and CCR8 are the functional receptors of this chemokine.

Recombinant Human LEC (CCL16)
MBS4159662-0025mg 0.025mg
EUR 385

Recombinant Human LEC (CCL16)
MBS4159662-1mg 1(mg)
EUR 4600

Recombinant Human LEC (CCL16)
MBS4159662-5x1mg 5x1mg
EUR 20445

Human LEC (CCL16) Recombinant
MBS553045-0005mg 0.005mg
EUR 165

Human LEC (CCL16) Recombinant
MBS553045-0025mg 0.025mg
EUR 245

Anti-Human LEC/NCC-4 Antibody
102-P51G 100 µg
EUR 245.7
Description: LEC or NCC-4 is a CC chemokine that can signal through the CCR8 and CCR1 receptors. It is expressed in the liver, spleen, and thymus. LEC is chemotactic towards monocytes and lymphocytes but not neutrophils. Recombinant human LEC is an 11.2 kDa protein containing 97 amino acid residues, including the four conserved cysteine residues present in CC chemokines.

Human LEC/CCL16 Antibody Pair Set
ABPR-ZB293 5 plates, 15 plates Ask for price
Description: Quantitative determination of Human LEC/CCL16

Anti-Human LEC Goat Polyclonal Antibody
TA328365 100 µg Ask for price

Human LEC/NCC-4 (CCL16)
MBS692056-0005mg 0.005mg
EUR 300

Human LEC/NCC-4 (CCL16)
MBS692056-002mg 0.02mg
EUR 450

Human LEC/NCC-4 (CCL16)
MBS692056-5x002mg 5x0.02mg
EUR 1725

Recombinant Human LEC (CCL16) Protein
PROTO15467-1 20ug
EUR 380.4
Description: LEC is a CC chemokine that can signal through the CCR8 and CCR1 receptors. It is expressed in the liver, spleen, and thymus. LEC is chemotactic towards monocytes and lymphocytes but not neutrophils. Recombinant human LEC is an 11.2 kDa protein containing 97 amino acid residues, including the four conserved cysteine residues present in CC chemokines.

Recombinant Human LEC/CCL16 protein
CD01396-5ug 5ug
EUR 176
  • > 97 % by SDS-PAGE and HPLC analyses.
Description: Human CCL16, also called Liver-expressed chemokine (LEC), Monotactin-1 (MTN-1), IL-10-inducible chemokine and so on, is expressed by the CCL16 gene located on the chromosome 17 in humans. The gene encodes a 120 a.a. residue precursor protein with a 23 a.a. residue predicted signal peptide that is cleaved to generate a 97 a.a. residue mature protein. The protein is secreted by the liver, thymus, spleen cells and showing chemotactic activity for lymphocytes and monocytes but it is distantly related to other CC chemokines, exhibiting less than 30 % sequence identity. CCL16 is highly induced by IL-10, IFN-γ and bacterial lipopolysaccharide in monmcytes and signal through CCR1, CCR2, CCR5, and CCR8.

LEC/NCC-4 Human Recombinant
rAP-0241 Inquiry Ask for price

Human LEC Recombinant Protein Lyophilized
IHULECRLY5UG each
EUR 341
  • Wet Ice
Description: Human LEC Recombinant Protein Lyophilized

Human LEC Recombinant Protein Lyophilized
MBS8432637-INQUIRE INQUIRE Ask for price

Biotinylated Anti-Human LEC Goat Polyclonal Antibody
TA328364 50 µg Ask for price

LEC antibody
10R-L115A 500 ug
EUR 240
  • Lyophilized from PBS.
Description: Mouse monoclonal LEC antibody

LEC antibody
70R-LG003 50 ug
EUR 312
  • Lyophilized from PBS, pH 7.2.
Description: Affinity purified Goat polyclonal LEC antibody

LEC antibody
MBS532318-05mg 0.5mg
EUR 370

LEC antibody
MBS532318-5x05mg 5x0.5mg
EUR 1525

LEC antibody
MBS535708-005mg 0.05mg
EUR 465

LEC antibody
MBS535708-5x005mg 5x0.05mg
EUR 1945

Recombinant Human LEC/NCC-4 (CCL16)
7-01792 5µg Ask for price

Recombinant Human LEC/NCC-4 (CCL16)
7-01793 20µg Ask for price

Recombinant Human LEC/NCC-4 (CCL16)
7-01794 1mg Ask for price

Recombinant Human LEC/NCC-4 (CCL16)
HECCP-1601 5ug Ask for price

Recombinant Human LEC/NCC-4 (CCL16)
MBS143272-0005mg 0.005mg
EUR 240

Recombinant Human LEC/NCC-4 (CCL16)
MBS143272-002mg 0.02mg
EUR 310

Recombinant Human LEC/NCC-4 (CCL16)
MBS143272-1mg 1mg
EUR 2880

Recombinant Human LEC/NCC-4 (CCL16)
MBS143272-5x1mg 5x1mg
EUR 12630

LEC / CCL16 / HCC4 Monoclonal antibody [Clone: LEC-14]
LEC-14-100ug 100 ug
EUR 141.79
  • Storage buffer: Produced in tissue culture, contains no host Ig. Antibodies are affinity purified and presented in PBS with 0,02% sodium azide.
Description: Identify and measure human LEC. Marker for inflammatory processes.

LEC / CCL16 / HCC4 Monoclonal antibody [Clone: LEC-14]
LEC-14-1mg 1 mg
EUR 897.6
  • Storage buffer: Produced in tissue culture, contains no host Ig. Antibodies are affinity purified and presented in PBS with 0,02% sodium azide.
Description: Identify and measure human LEC. Marker for inflammatory processes.

LEC / CCL16 / HCC4 Monoclonal antibody [Clone: LEC-14]
LEC-14-500ug 500 ug
EUR 479.6
  • Storage buffer: Produced in tissue culture, contains no host Ig. Antibodies are affinity purified and presented in PBS with 0,02% sodium azide.
Description: Identify and measure human LEC. Marker for inflammatory processes.

LEC / CCL16 / HCC4 Monoclonal antibody [Clone: LEC-57]
LEC-57-100ug 100 ug
EUR 141.79
  • Storage buffer: Produced in tissue culture, contains no host Ig. Antibodies are affinity purified and presented in PBS with 0,02% sodium azide.
Description: Identify and measure human LEC. Marker for inflammatory processes.

LEC / CCL16 / HCC4 Monoclonal antibody [Clone: LEC-57]
LEC-57-1mg 1 mg
EUR 897.6
  • Storage buffer: Produced in tissue culture, contains no host Ig. Antibodies are affinity purified and presented in PBS with 0,02% sodium azide.
Description: Identify and measure human LEC. Marker for inflammatory processes.

LEC / CCL16 / HCC4 Monoclonal antibody [Clone: LEC-57]
LEC-57-500ug 500 ug
EUR 479.6
  • Storage buffer: Produced in tissue culture, contains no host Ig. Antibodies are affinity purified and presented in PBS with 0,02% sodium azide.
Description: Identify and measure human LEC. Marker for inflammatory processes.

LEC/CCL16 Matched ELISA Antibody Pair Set, Human
MBS8118261-15Plates 15Plates
EUR 600

LEC/CCL16 Matched ELISA Antibody Pair Set, Human
MBS8118261-5Plates 5Plates
EUR 345

LEC/CCL16 Matched ELISA Antibody Pair Set, Human
MBS8118261-5x15Plates 5x15Plates
EUR 2755

HCC-4, LEC, NCC-4, CCL16, human
RC315-27 5ug
EUR 125.26
  • Product category: Proteins/Recombinant Proteins/Cytokines

Human LEC/NCC-4 (CCL16) Recombinant Protein
100-060 20 µg
EUR 196.35
Description: LEC is a CC chemokine that can signal through the CCR8 and CCR1 receptors. It is expressed in the liver, spleen, and thymus. LEC is chemotactic towards monocytes and lymphocytes but not neutrophils. Recombinant human LEC is an 11.2 kDa protein containing 97 amino acid residues, including the four conserved cysteine residues present in CC chemokines.

Human LEC/NCC-4 (CCL16) Recombinant Protein
100-060S 5 µg
EUR 92.4
Description: LEC is a CC chemokine that can signal through the CCR8 and CCR1 receptors. It is expressed in the liver, spleen, and thymus. LEC is chemotactic towards monocytes and lymphocytes but not neutrophils. Recombinant human LEC is an 11.2 kDa protein containing 97 amino acid residues, including the four conserved cysteine residues present in CC chemokines.

LEC (CCL16) (NM_004590) Human Over-expression Lysate
LS006360 100ug
EUR 628
  • Human
Description: Transient overexpression lysate of chemokine (C-C motif) ligand 16 (CCL16)

CCL16 LEC/NCC-4 Human Recombinant Protein
PROTO15467 Regular: 20ug
EUR 380.4
Description: CCL16 Human Recombinant produced in E.Coli is a non-glycosylated, Polypeptide chain containing 97 amino acids and having a molecular mass of 11.2 kDa. ;The CCL16 is purified by proprietary chromatographic techniques.

LEC/CCL16 Protein, Human, Recombinant (His Tag)
MBS8120314-005mg 0.05mg
EUR 340

LEC/CCL16 Protein, Human, Recombinant (His Tag)
MBS8120314-1mg 1mg
EUR 2530

LEC/CCL16 Protein, Human, Recombinant (His Tag)
MBS8120314-5x1mg 5x1mg
EUR 11240

LEC/CCL16 Protein, Human, Recombinant (His Tag)
MBS8120315-005mg 0.05mg
EUR 340

LEC/CCL16 Protein, Human, Recombinant (His Tag)
MBS8120315-5x005mg 5x0.05mg
EUR 1380

LEC, NCC-4, Human (Liver-Expressed Chemokine)
MBS635010-0005mg 0.005mg
EUR 340

LEC, NCC-4, Human (Liver-Expressed Chemokine)
MBS635010-002mg 0.02mg
EUR 490

LEC, NCC-4, Human (Liver-Expressed Chemokine)
MBS635010-5x002mg 5x0.02mg
EUR 2055

LEC Chemokine(LEC66) Antibody
BNC040066-100 100uL
EUR 238.8
Description: Primary antibody against LEC Chemokine(LEC66), CF405S conjugate, Concentration: 0.1mg/mL

LEC Chemokine(LEC66) Antibody
BNC040066-500 500uL
EUR 652.8
Description: Primary antibody against LEC Chemokine(LEC66), CF405S conjugate, Concentration: 0.1mg/mL

LEC Chemokine(LEC67) Antibody
BNC040067-100 100uL
EUR 238.8
Description: Primary antibody against LEC Chemokine(LEC67), CF405S conjugate, Concentration: 0.1mg/mL

LEC Chemokine(LEC67) Antibody
BNC040067-500 500uL
EUR 652.8
Description: Primary antibody against LEC Chemokine(LEC67), CF405S conjugate, Concentration: 0.1mg/mL

LEC Chemokine(LEC66) Antibody
BNC810066-100 100uL
EUR 238.8
Description: Primary antibody against LEC Chemokine(LEC66), CF680R conjugate, Concentration: 0.1mg/mL

LEC Chemokine(LEC66) Antibody
BNC810066-500 500uL
EUR 652.8
Description: Primary antibody against LEC Chemokine(LEC66), CF680R conjugate, Concentration: 0.1mg/mL

LEC Chemokine(LEC67) Antibody
BNC810067-100 100uL
EUR 238.8
Description: Primary antibody against LEC Chemokine(LEC67), CF680R conjugate, Concentration: 0.1mg/mL

LEC Chemokine(LEC67) Antibody
BNC810067-500 500uL
EUR 652.8
Description: Primary antibody against LEC Chemokine(LEC67), CF680R conjugate, Concentration: 0.1mg/mL

LEC Chemokine(LEC66) Antibody
BNC940066-100 100uL
EUR 238.8
Description: Primary antibody against LEC Chemokine(LEC66), CF594 conjugate, Concentration: 0.1mg/mL

LEC Chemokine(LEC66) Antibody
BNC940066-500 500uL
EUR 652.8
Description: Primary antibody against LEC Chemokine(LEC66), CF594 conjugate, Concentration: 0.1mg/mL

LEC Chemokine(LEC67) Antibody
BNC940067-100 100uL
EUR 238.8
Description: Primary antibody against LEC Chemokine(LEC67), CF594 conjugate, Concentration: 0.1mg/mL

LEC Chemokine(LEC67) Antibody
BNC940067-500 500uL
EUR 652.8
Description: Primary antibody against LEC Chemokine(LEC67), CF594 conjugate, Concentration: 0.1mg/mL

LEC Chemokine(LEC66) Antibody
BNC880066-100 100uL
EUR 238.8
Description: Primary antibody against LEC Chemokine(LEC66), CF488A conjugate, Concentration: 0.1mg/mL

LEC Chemokine(LEC66) Antibody
BNC880066-500 500uL
EUR 652.8
Description: Primary antibody against LEC Chemokine(LEC66), CF488A conjugate, Concentration: 0.1mg/mL

LEC Chemokine(LEC67) Antibody
BNC880067-100 100uL
EUR 238.8
Description: Primary antibody against LEC Chemokine(LEC67), CF488A conjugate, Concentration: 0.1mg/mL

LEC Chemokine(LEC67) Antibody
BNC880067-500 500uL
EUR 652.8
Description: Primary antibody against LEC Chemokine(LEC67), CF488A conjugate, Concentration: 0.1mg/mL

LEC Chemokine(LEC66) Antibody
BNC430066-100 100uL
EUR 238.8
Description: Primary antibody against LEC Chemokine(LEC66), CF543 conjugate, Concentration: 0.1mg/mL

LEC Chemokine(LEC66) Antibody
BNC430066-500 500uL
EUR 652.8
Description: Primary antibody against LEC Chemokine(LEC66), CF543 conjugate, Concentration: 0.1mg/mL

LEC Chemokine(LEC67) Antibody
BNC430067-100 100uL
EUR 238.8
Description: Primary antibody against LEC Chemokine(LEC67), CF543 conjugate, Concentration: 0.1mg/mL

LEC Chemokine(LEC67) Antibody
BNC430067-500 500uL
EUR 652.8
Description: Primary antibody against LEC Chemokine(LEC67), CF543 conjugate, Concentration: 0.1mg/mL

LEC Chemokine(LEC66) Antibody
BNC050066-100 100uL
EUR 238.8
Description: Primary antibody against LEC Chemokine(LEC66), CF405M conjugate, Concentration: 0.1mg/mL

Intramolecular Photoelectrochemical System Utilizing Tyrosine-Modified Antibody-Focused Peptide as Electron Donor for Detection of Biomarkers

An intramolecular photoelectrochemical (PEC) system is designed from the novel electron donor YYYHWRGWV (Y3-H) peptide ligand for the primary time. The bifunctional nonapeptide can’t solely depend on the HWRGWV sequence as a site-oriented immobilizer to acknowledge the crystallizable fragment (Fc) domains of the antibody but additionally acts as electron donors for PEC technology through three tyrosine (Y) of the N-terminal.
The Bi2WO6/AgInS2 heterojunction with a major visible-light absorption is utilized as a photoelectric generator, and the motivation is ascribed to a confirmed proposition, specifically, that short-wavelength illuminant radiates proteins, inflicting a decline in bioactivity of immune protein.
An modern biosensor is fabricated utilizing the above methods for the detection of CYFRA21-1, a biomarker of squamous cell lung carcinoma. This kind of PEC-based sensing platform reveals convincing experimental information and might be an efficient candidate for medical software sooner or later attributable to their extraordinarily skillful conception.

Antibodies from A number of Sclerosis Mind Recognized Epstein-Barr Virus Nuclear Antigen 1 & 2 Epitopes which Are Acknowledged by Oligoclonal Bands

A number of sclerosis (MS) is a continual inflammatory demyelinating illness of the central nervous system (CNS), the etiology of which is poorly understood. The commonest laboratory abnormality related to MS is elevated intrathecal immunoglobulin G (IgG) synthesis and the presence of oligoclonal bands (OCBs) within the mind and cerebrospinal fluid (CSF).
Nonetheless, the most important antigenic targets of those antibody responses are unknown. The chance of MS is elevated after infectious mononucleosis (IM) attributable to EBV an infection, and MS sufferers have larger serum titers of anti-EBV antibodies than management populations. Our purpose was to determine disease-relevant epitopes of IgG antibodies in MS; to take action, we screened phage-displayed random peptide libraries (12-mer) with whole IgG antibodies purified from the mind of a affected person with acute MS.
We recognized and characterised the phage peptides for binding specificity to intrathecal IgG from sufferers with MS and from controls by ELISA, phage-mediated Immuno-PCR, and isoelectric focusing.
We recognized two phage peptides that share sequence homologies with EBV nuclear antigens 1 and a couple of (EBNA1 and EBNA2), respectively. The specificity of the EBV epitopes discovered by panning with MS mind IgG was confirmed by ELISA and aggressive inhibition assays.
Utilizing a extremely delicate phage-mediated immuno-PCR assay, we decided particular bindings of the 2 EBV epitopes to IgG from CSF from 46 MS and 5 inflammatory management (IC) sufferers. MS CSF IgG have considerably larger bindings to EBNA1 epitope than to EBNA2 epitope, whereas EBNA1 and EBNA2 didn’t considerably differ in binding to IC CSF IgG.
Additional, the EBNA1 epitope was acknowledged by OCBs from a number of MS CSF as proven in blotting assays with samples separated by isoelectric focusing. The EBNA1 epitope is reactive to MS intrathecal antibodies equivalent to oligoclonal bands.
This reinforces the potential function of EBV within the etiology of MS. Graphical summary Antibodies purified from an MS mind plaque had been panned by phage show peptide libraries to discern potential antigens. Phage displaying peptide sequences resembling Epstein-Barr Virus Nuclear Antigens 1 & 2 (EBNA1 & 2) epitopes had been recognized. Antibodies from sera and CSF from different MS sufferers additionally reacted to these epitopes.

BRAK, Recombinant, Human
MBS650956-002mg 0.02mg
EUR 490

BRAK, Recombinant, Human
MBS650956-5x002mg 5x0.02mg
EUR 2055

Human BRAK ELISA Kit
EHB0616 96Tests
EUR 625.2

Human BRAK GENLISA ELISA
KBH0061 1 x 96 wells
EUR 286

Recombinant Human BRAK (CXCL14)
7-01783 5µg Ask for price

Recombinant Human BRAK (CXCL14)
7-01784 20µg Ask for price

Recombinant Human BRAK (CXCL14)
7-01785 1mg Ask for price

Recombinant Human BRAK (CXCL14)
MBS145415-0005mg 0.005mg
EUR 240

Recombinant Human BRAK (CXCL14)
MBS145415-002mg 0.02mg
EUR 310

Recombinant Human BRAK (CXCL14)
MBS145415-1mg 1mg
EUR 2880

Recombinant Human BRAK (CXCL14)
MBS145415-5x1mg 5x1mg
EUR 12630

Recombinant Human BRAK protein
CD02230-10ug 10ug
EUR 275
  • Greater than 95% as determined by reducing SDS-PAGE.
Description: Recombinant Human C-X-C Motif Chemokine 14 is produced by our E.coli expression system and the target gene encoding Ser35-Glu111 is expressed.

Recombinant Human BRAK protein
CD02230-50ug 50ug
EUR 823
  • Greater than 95% as determined by reducing SDS-PAGE.
Description: Recombinant Human C-X-C Motif Chemokine 14 is produced by our E.coli expression system and the target gene encoding Ser35-Glu111 is expressed.

CXCL14/BRAK, human recombinant
4278-10 each
EUR 288

CXCL14/BRAK, human recombinant
4278-1000 each
EUR 3348

CXCL14/BRAK, human recombinant
4278-50 each
EUR 705.6

Recombinant Human CXCL14 (BRAK)
Z102375 20 µg
EUR 195
Description: Chemokine (CXC motif) ligand 14, also known as breast and kidney-expressed chemokine (BRAK), is a CXC chemokine that is a potent chemoattractant for neutrophils but not for T-cells, B-cells, monocytes or granulocytes. Mature CXCL14 has many conserved features of the CXC family and is 30% homologous to the MIP-α and MIP-β sequences, but differs in that it has an additional five amino acid sequence in between the third and fourth cysteines and a short N-terminus. It is usually highly expressed near its fibroblast source and in epidermal fibroblasts and keratinocytes of skin, but is absent from cancer cells.

Recombinant Human CXCL14 (BRAK)
Z102379 1.0 mg
EUR 3900
Description: Chemokine (CXC motif) ligand 14, also known as breast and kidney-expressed chemokine (BRAK), is a CXC chemokine that is a potent chemoattractant for neutrophils but not for T-cells, B-cells, monocytes or granulocytes. Mature CXCL14 has many conserved features of the CXC family and is 30% homologous to the MIP-α and MIP-β sequences, but differs in that it has an additional five amino acid sequence in between the third and fourth cysteines and a short N-terminus. It is usually highly expressed near its fibroblast source and in epidermal fibroblasts and keratinocytes of skin, but is absent from cancer cells.

BRAK (CXCL14) Human Recombinant
rAP-0116 Inquiry Ask for price

Recombinant Human CXCL14 (BRAK)
MBS4159847-002mg 0.02mg
EUR 345

Recombinant Human CXCL14 (BRAK)
MBS4159847-1mg 1(mg)
EUR 4600

Recombinant Human CXCL14 (BRAK)
MBS4159847-5x1mg 5x1mg
EUR 20445

Anti-Human BRAK Rabbit Polyclonal Antibody
TA328274 100 µg Ask for price

Mouse Monoclonal anti-human CXCL14 (BRAK)
hAP-0213 100ug
EUR 250

Sheep Polyclonal anti-Human CXCL14 (BRAK)
hAP-5820 50ug
EUR 400

Human CXCL14/BRAK ELISA Kit
E16HE0215 96T
EUR 833.33

Human BRAK (CXCL14) Recombinant Protein
100-139 20 µg
EUR 196.35
Description: Breast and Kidney-expressed chemokine (BRAK) is a CXC chemokine expressed in normal tissue in the absence of inflammatory stimuli, and infrequently expressed in cancer cell lines. BRAK is known to be a highly selective monocyte chemoattractant. However, main function and receptor selectivity is unknown at this time. BRAK contains the four highly conserved cysteine residues present in CXC chemokines. The sequence of the mature protein consists of 87 amino acid residues, and is approximately 30% homologous to the sequences of MIP-2 alpha and beta. Recombinant human BRAK is a 9.4 kDa protein containing 77 amino acid residues.

Human BRAK (CXCL14) Recombinant Protein
100-139S 5 µg
EUR 92.4
Description: Breast and Kidney-expressed chemokine (BRAK) is a CXC chemokine expressed in normal tissue in the absence of inflammatory stimuli, and infrequently expressed in cancer cell lines. BRAK is known to be a highly selective monocyte chemoattractant. However, main function and receptor selectivity is unknown at this time. BRAK contains the four highly conserved cysteine residues present in CXC chemokines. The sequence of the mature protein consists of 87 amino acid residues, and is approximately 30% homologous to the sequences of MIP-2 alpha and beta. Recombinant human BRAK is a 9.4 kDa protein containing 77 amino acid residues.

Recombinant Human BRAK (CXCL14) Protein
PROTO95715-2 20ug
EUR 380.4
Description: Breast and Kidney-expressed chemokine (BRAK) is a CXC chemokine expressed in normal tissue in the absence of inflammatory stimuli, and infrequently expressed in cancer cell lines. BRAK is known to be a highly selective monocyte chemoattractant. However, main function and receptor selectivity is unknown at this time. BRAK contains the four highly conserved cysteine residues present in CXC chemokines. The sequence of the mature protein consists of 87 amino acid residues, and is approximately 30% homologous to the sequences of MIP-2 α and β. Recombinant human BRAK is a 9.4 kDa protein containing 77 amino acid residues.

Human BRAK Recombinant Protein Lyophilized
IHUBRAKRLY5UG each
EUR 341
  • Wet Ice
Description: Human BRAK Recombinant Protein Lyophilized

Human BRAK Recombinant Protein Lyophilized
MBS8431375-INQUIRE INQUIRE Ask for price

Recombinant Human CXCL14/BRAK Protein
E40KMP1499 20ug
EUR 495

BRAK (CXCL14) Human Recombinant Protein
PROTO95715 Regular: 20ug
EUR 380.4
Description: CXCL14 Human Recombinant produced in E.Coli is a single, non-glycosylated, Polypeptide chain containing 77 amino acids and having a molecular mass of 9.4kDa.;The CXCL14 is purified by proprietary chromatographic techniques.

Recombinant Human CXCL14/BRAK Protein
RP00348 10 μg
EUR 1137.5
  • This antimicrobial protein belongs to the cytokine family which encode secreted proteins involved in immunoregulatory and inflammatory processes. The protein encoded by this gene is structurally related to the CXC (Cys-X-Cys) subfamily of cytokines.
  • Show more

BRAK
chm-001 5µg
EUR 60
Description: Recombinant Human BRAK (CXCL14)

BRAK antibody
70R-BR016 50 ug
EUR 312
  • Lyophilized from PBS, pH 7.2.
Description: Affinity purified Rabbit polyclonal BRAK antibody

BRAK antibody
MBS535940-005mg 0.05mg
EUR 465

BRAK antibody
MBS535940-5x005mg 5x0.05mg
EUR 1945

Recombinant Human BRAK (CXCL14), His Tag
7-01780 5µg Ask for price

Recombinant Human BRAK (CXCL14), His Tag
7-01781 20µg Ask for price

Recombinant Human BRAK (CXCL14), His Tag
7-01782 1mg Ask for price

Recombinant Human BRAK (CXCL14), His Tag
MBS143271-0001mg 0.001mg
EUR 240

Recombinant Human BRAK (CXCL14), His Tag
MBS143271-0005mg 0.005mg
EUR 310

Recombinant Human BRAK (CXCL14), His Tag
MBS143271-005mg 0.05mg
EUR 1360

Recombinant Human BRAK (CXCL14), His Tag
MBS143271-5x005mg 5x0.05mg
EUR 5800

Biotinylated Anti-Human BRAK Rabbit Polyclonal Antibody
TA328273 50 µg Ask for price

BRAK Human Recombinant (CXCL14), His-Tag
rAP-0119 Inquiry Ask for price

Human BRAK Flow Cytometry Assay - Group 6
HX87213 96 Tests
EUR 270

Nori® Human CXCL14/BRAK ELISA Kit
GR106314 96-well
EUR 461

Human, BRAK Human Recombinant Protein (CXCL14), His-Tag
PROTO95715-1 Regular: 5ug
EUR 380.4
Description: CXCL14 Human Recombinant produced in E.Coli is a single, non-glycosylated, polypeptide chain containing 88 amino acids and having a molecular mass of 10.66 kDa. ;The Human BRAK contains a 10 a.a. fusion His tag at N-Terminus. ;The BRAK is purified by proprietary chromatographic techniques.

Recombinant Human BRAK Protein, His, E.coli-1ug
QP11201-1ug 1ug
EUR 186

Recombinant Human BRAK Protein, His, E.coli-5ug
QP11201-5ug 5ug
EUR 241.2

Recombinant Human BRAK Protein, His, E.coli-50ug
QP11201-50ug 50ug
EUR 1513.2

BRAK (AP)
MBS6465940-01mL 0.1mL
EUR 635

BRAK (AP)
MBS6465940-5x01mL 5x0.1mL
EUR 2700

BRAK (PE)
MBS6465950-01mL 0.1mL
EUR 635

BRAK (PE)
MBS6465950-5x01mL 5x0.1mL
EUR 2700

BRAK His
chm-239 1µg
EUR 60
Description: Recombinant Human BRAK (CXCL14), His Tag

BRAK (APC)
MBS6465941-01mL 0.1mL
EUR 635

BRAK (APC)
MBS6465941-5x01mL 5x0.1mL
EUR 2700

BRAK (HRP)
MBS6465944-01mL 0.1mL
EUR 635

BRAK (HRP)
MBS6465944-5x01mL 5x0.1mL
EUR 2700

BRAK (FITC)
MBS6465943-01mL 0.1mL
EUR 635

BRAK (FITC)
MBS6465943-5x01mL 5x0.1mL
EUR 2700

Recombinant Human BRAK Protein, Untagged, E.coli-1mg
QP10538-1mg 1mg
EUR 3308.4

Recombinant Human BRAK Protein, Untagged, E.coli-5ug
QP10538-5ug 5ug
EUR 186

Recombinant Human CXCL14/BRAK protein, No Tag
MBS1560747-005mg 0.05mg
EUR 320

Recombinant Human CXCL14/BRAK protein, No Tag
MBS1560747-01mg 0.1mg
EUR 410

Recombinant Human CXCL14/BRAK protein, No Tag
MBS1560747-5x01mg 5x0.1mg
EUR 1520

Recombinant Human BRAK Protein, Untagged, E.coli-20ug
QP10538-20ug 20ug
EUR 241.2

BRAK (Biotin)
MBS6465942-01mL 0.1mL
EUR 635

BRAK (Biotin)
MBS6465942-5x01mL 5x0.1mL
EUR 2700

BRAK (Biotin)
MBS618734-0025mg 0.025mg
EUR 420

BRAK (Biotin)
MBS618734-005mg 0.05mg
EUR 525

BRAK (Biotin)
MBS618734-5x005mg 5x0.05mg
EUR 2210

CXCL14 (BRAK)
MBS517297-002mg 0.02mg
EUR 290

CXCL14 (BRAK)
MBS517297-1mg 1mg
EUR 3715

CXCL14 (BRAK)
MBS517297-5x1mg 5x1mg
EUR 16450

BRAK protein
30R-AB037 20 ug
EUR 312
  • Supplied as a lyophilized powder.
Description: Human recombinant BRAK protein

BRAK protein
MBS539458-002mg 0.02mg
EUR 465

BRAK protein
MBS539458-5x002mg 5x0.02mg
EUR 1945

Breast And Kidney Expressed Chemokine (BRAK) Polyclonal Antibody (Human)
4-PAB607Hu01
  • Ask for price
  • Ask for price
  • Ask for price
  • Ask for price
  • Ask for price
  • 100ul
  • 10ml
  • 1ml
  • 200ul
  • 20ul
  • Sequence of the immunogen: BRAK (Ser35~Glu111)
  • Buffer composition: 0.01M PBS, pH7.4, containing 0.05% Proclin-300, 50% glycerol.
Description: A Rabbit polyclonal antibody against Human Breast And Kidney Expressed Chemokine (BRAK)